Press Releases

Printer Friendly Version View printer-friendly version
<< Back
Download PDF Download PDF
Vitae Pharmaceuticals Among 2014 Best Places to Work in PA
Marks Fifth Consecutive Year Vitae Has Made the List

FORT WASHINGTON, Pa., Dec. 8, 2014 (GLOBE NEWSWIRE) -- Vitae Pharmaceuticals, Inc. (Nasdaq:VTAE), a clinical-stage biotechnology company, today announced it was named one of the 100 Best Places to Work in PA for the fifth consecutive year.

"I'm proud that Vitae has been recognized as a great place to work in Pennsylvania, now for five years in a row," said Jeffrey Hatfield, President and Chief Executive Officer of Vitae. "It's a testament to the open communication, teamwork, and respect among employees that has evolved here, which is absolutely essential to our mission at Vitae. By having such a positive team culture, we are able to solve the most difficult drug discovery challenges and develop breakthrough treatments for patients suffering from significant diseases for which there are serious unmet medical needs."

Since 2000, the Best Places to Work in PA awards program has sought to identify and honor the best places of employment in Pennsylvania. Winners are selected based on the results of a two-part company assessment, including a questionnaire on employer policies and practices, and an employee engagement and satisfaction survey.

The Best Places to Work in PA program is a public/private partnership between Team Pennsylvania Foundation, the Pennsylvania Department of Community and Economic Development, the Pennsylvania State Council of the Society for Human Resource Management, and the Central Penn Business Journal. For more information, visit www.bestplacestoworkinpa.com.

About Vitae Pharmaceuticals

Vitae Pharmaceuticals is a clinical-stage biotechnology company focused on discovering and developing novel, small molecule drugs for diseases in which there are significant unmet medical needs. The company is developing a robust and growing portfolio of novel product candidates generated by Contour®, its proprietary structure- based drug discovery platform.

For additional information, please visit the company's website at www.vitaepharma.com.

CONTACT: INVESTORS:
         Vitae Pharmaceuticals, Inc.
         Richard S. Morris, CPA
         Chief Financial Officer
         (215) 461-2000
         rmorris@vitaerx.com

         Westwicke Partners
         John Woolford
         (443) 213-0506
         john.woolford@westwicke.com

         MEDIA:
         6 Degrees PR
         Tony Plohoros
         (908) 940-0135
         tplohoros@6degreespr.com

Vitae Logo

Vitae Pharmaceuticals